The Effects of Carmopennum on Secondary Infection

We randomized 607 patients, 303 in the continuous infusion group and 304 in the intermittent one. And with a P alpha value of 2005 and the power of 80 percent, we got math for 570 patients that was rounded to 600 for counting for lost and full up. We have 900 more or less patients that met in Cluzone criteria. We have 30% more or less screening failure. Only one patient received by mistake not by deliberate crossover, the intermittent treatment in the continuous arm. Then we have our patient. They are all included in our main analysis that is based on intention to treat.